Home / Health / Gulf War Sparks NHS Supply Crisis Fears
Gulf War Sparks NHS Supply Crisis Fears
26 Apr
Summary
- Shipping standstill in the Gulf threatens NHS with medicine and product shortages.
- The NHS faces rising costs for essential medical supplies due to war impact.
- Disruption could lead to price gouging and scarcity of crucial items.

The NHS faces a critical juncture as the war in Iran triggers fears of severe shortages and escalating costs for vital medicines and medical supplies. The ongoing shipping standstill in the Gulf has disrupted the flow of petrochemicals essential for producing everything from pharmaceuticals to sterile single-use items. As one of the world's largest healthcare bulk buyers, the NHS's annual spending of £8 billion on equipment and £21.6 billion on medicines is now at risk.
Experts warn that the conflict could widen and deepen existing supply chain issues, exacerbated by Brexit and the pandemic. NHS England's chief executive, Jim Mackey, has expressed significant concern, suggesting the need for additional government funding if price increases become substantial. To mitigate risks, NHS England has increased purchases of drugs and devices, though prolonged conflict could still strain current buffer stocks.
The disruption extends to air freight, with major hubs like Dubai and Doha affected, impacting the movement of medicines from India, a key global supplier. The price of essential materials like naphtha, used in many healthcare products, has surged, leading to significant price hikes from suppliers. For instance, the cost of synthetic rubber gloves has jumped by 40%, and further shortages are anticipated by late May.
Furthermore, manufacturers are facing increased costs for materials like polyester fibre and PET resin, impacting the production of surgical masks, gowns, and pharmaceutical bottles. This situation could lead to price gouging and scarcity of components for advanced medical equipment. The NHS, known for securing some of the lowest global prices, may have to contend with higher costs or risk manufacturers prioritizing other markets.
To address these challenges, the NHS is reinforcing buffer stocks and exploring alternative procurement options. While essential medicines remain largely in good supply, the long-term resilience of the healthcare supply chain is a growing concern. Experts suggest a potential shift towards more sensible use of single-use items and bringing manufacturing closer to home to secure future supply.